Barry G. Arnason to Immunosuppressive Agents
This is a "connection" page, showing publications Barry G. Arnason has written about Immunosuppressive Agents.
Connection Strength
0.231
-
Immunoglobulin-like transcript 3, an inhibitor of T cell activation, is reduced on blood monocytes during multiple sclerosis relapses and is induced by interferon beta-1b. Mult Scler. 2010 Jan; 16(1):30-8.
Score: 0.061
-
Terbutaline in myasthenia gravis: a pilot study. J Neurol Sci. 2009 Feb 15; 277(1-2):150-4.
Score: 0.057
-
The effect of short-term and chronic immunosuppression on Theiler's virus demyelination. J Neuroimmunol. 1982 Jun; 2(3-4):223-34.
Score: 0.036
-
Immunologic therapy of multiple sclerosis. Annu Rev Med. 1999; 50:291-302.
Score: 0.029
-
Immunoaugmenting effect of FK 506 on experimental allergic encephalomyelitis in Lewis rats. J Autoimmun. 1998 Aug; 11(4):329-34.
Score: 0.028
-
Multiple sclerosis: current concepts and management. Hosp Pract (Off Ed). 1982 Feb; 17(2):81-9.
Score: 0.009
-
Suppression of experimental allergic encephalomyelitis in guinea-pigs with poly-L-lysine. Clin Exp Immunol. 1975 Dec; 22(3):539-45.
Score: 0.006
-
Partial suppression of experimental allergic encephalomyelitis with heparin. Arch Neurol. 1972 Aug; 27(2):153-8.
Score: 0.005